These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21484108)

  • 1. Expression level of glutamine synthetase is increased in hepatocellular carcinoma and liver tissue with cirrhosis and chronic hepatitis B.
    Long J; Wang H; Lang Z; Wang T; Long M; Wang B
    Hepatol Int; 2011 Jun; 5(2):698-706. PubMed ID: 21484108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.
    Ma LN; Liu XY; Lu ZH; Wu LG; Tang YY; Luo X; Hu YC; Yan TT; Wang Q; Ding XC; Xie Y
    Oncol Lett; 2017 May; 13(5):3457-3464. PubMed ID: 28521452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma.
    Wang X; Li MM; Niu Y; Zhang X; Yin JB; Zhao CJ; Wang RT
    Dis Markers; 2019; 2019():5945721. PubMed ID: 31485278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine synthetase promotes tumor invasion in hepatocellular carcinoma through mediating epithelial-mesenchymal transition.
    Liu P; Lu D; Al-Ameri A; Wei X; Ling S; Li J; Zhu H; Xie H; Zhu L; Zheng S; Xu X
    Hepatol Res; 2020 Feb; 50(2):246-257. PubMed ID: 31652385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis.
    Pan HY; Wu QQ; Yin QQ; Dai YN; Huang YC; Zheng W; Hui TC; Chen MJ; Wang MS; Zhang JJ; Huang HJ; Tong YX
    ACS Omega; 2021 Jan; 6(2):1160-1170. PubMed ID: 33490775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of serum DSA-TRF in hepatocellular carcinoma.
    Guan W; Gao Z; Huang C; Fang M; Feng H; Chen S; Wang M; Zhou J; Hong S; Gao C
    Glycoconj J; 2020 Apr; 37(2):231-240. PubMed ID: 31933068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
    Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4210 Da and 1866 Da polypeptides as potential biomarkers of liver disease progression in hepatitis B virus patients.
    Ren Y; Yang L; Li M; Wang J; Yan H; Ma N; Liu W; Wang L; Gao X; Gao P; Li T; Liu D
    Sci Rep; 2021 Aug; 11(1):16982. PubMed ID: 34417517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
    Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
    Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.
    Liu Y; Jin J; Ji J; Gao XM; Fan YC
    Virol J; 2019 Oct; 16(1):120. PubMed ID: 31661000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
    Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
    World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.
    Jun CH; Hong HJ; Chung MW; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    World J Gastroenterol; 2013 Oct; 19(40):6834-41. PubMed ID: 24187458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma.
    Shi J; Wang Y; Wang F; Zhu Z; Gao Y; Zhang Q; Du Z
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):855-864. PubMed ID: 32205116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sFRP-4, a potential novel serum marker for chronic hepatitis B-related hepatocellular carcinoma.
    Xu C; Zeng XH; Wang L; Tao SQ; Wu QX; Zhu P; Deng GH; Wang YM
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):164-70. PubMed ID: 25865689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.